About
10,040.00ILA+160.00 +1.62%
Closed • Updated at 18:06 GMT+00:00Market Cap$40.24B
P/E Ratio22.68
Volume1.16M
Beta0.45
RSI50.34
Gross Margin52.17%
Teva Pharmaceutical Industries Limited — investor relations, events, news, and company updates on 6ix.
Latest News
May 18 2026
Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
May 11 2026
Deckers Brands Announces Conference Call to Review Fourth Quarter and Full Fiscal Year 2026 Earnings Results
May 4 2026
Teva to Present at the BofA Securities Health Care Conference
Apr 29 2026
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
Apr 29 2026
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Google Übersetzer